Latha Velayudhan
Leicester, ENG, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 75 publications
A Systematic Review of Effects of Cholinesterase Inhibitors and Memantine on Cognitive Domains in Alzheimer's Disease.
Journal: Journal of geriatric psychiatry and neurology
Published: August 12, 2026
Social determinants and mental health in older adults.
Journal: International psychogeriatrics
Published: June 20, 2025
Lipid profiling reveals unsaturated lipid reduction in women with Alzheimer's disease.
Journal: Alzheimer's & dementia : the journal of the Alzheimer's Association
Published: March 11, 2025
Gray Matter Volume Loss in Parkinson's Disease Psychosis and Cannabinoid Receptor Gene Expression in the Brain.
Journal: Movement disorders : official journal of the Movement Disorder Society
Published: February 19, 2025
Aprosopsia: a novel metamorphopsia variant occurring in Parkinson's disease psychosis.
Journal: Journal of neurology
Published: February 17, 2025
The SLaM Brain Health Clinic: remote biomarker enhanced memory clinic for people with mild cognitive impairment within a National Health Service mental health trust.
Journal: BJPsych open
Published: December 19, 2024
Sativex (nabiximols) for the treatment of Agitation & Aggression in Alzheimer's dementia in UK nursing homes: a randomised, double-blind, placebo-controlled feasibility trial.
Journal: Age and ageing
Published: December 14, 2024
Decline in striatal binding ratio associated with accelerated decline in performance on symbol digit modality but not MoCA in Parkinson's Disease Psychosis.
Journal: BMJ mental health
Published: October 24, 2024
Adverse events caused by cannabinoids in middle aged and older adults for all indications: a meta-analysis of incidence rate difference.
Journal: Age and ageing
Published: April 29, 2024
Parkinson's disease psychosis associated with accelerated multidomain cognitive decline.
Journal: BMJ mental health
Published: March 05, 2024
Cannabidiol for behavior symptoms in Alzheimer's disease (CANBiS-AD): a randomized, double-blind, placebo-controlled trial.
Journal: International psychogeriatrics
Published: February 22, 2024
Last Updated: 09/26/2026